ArticleCancer immunology, immunotherapy : CII2023

Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study.

Lushan Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.